Search - tctmd.com

Displaying 201 - 220 of 458

Sort: Relevancy | Date

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

August 30, 2022

Smartphone App Can Detect AF, Influence Care: eBRAVE-AF

News Conference News ESC 2022

Smartphone App Can Detect AF, Influence Care: eBRAVE-AF

August 30, 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

August 28, 2022

More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

Higher BP, Oxygen Targets No Help in Comatose OHCA Patients: BOX

News Conference News ESC 2022

Higher BP, Oxygen Targets No Help in Comatose OHCA Patients: BOX

August 27, 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

TIME of Antihypertensive Dose Doesn’t Matter for CV Protection Open With no difference between nighttime and morning dosing, “patients can take their tablets whenever it’s convenient.” configuration options With no difference between nighttime and morning dosing, “patients can take their tablets whenever it’s convenient.”

News Conference News ESC 2022

TIME of Antihypertensive Dose Doesn’t Matter for CV Protection

August 26, 2022

Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty

News Daily News

Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty

August 25, 2022

More HF, Worse Long-term Outcomes in TAVI Patients Who Get Pacemakers

News Daily News

More HF, Worse Long-term Outcomes in TAVI Patients Who Get Pacemakers

August 24, 2022

Steep Rise in PVAD Support for Protected PCI: Medicare Data

News Daily News

Steep Rise in PVAD Support for Protected PCI: Medicare Data

August 19, 2022

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

News Daily News

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

August 19, 2022

VTE Risk Higher With COVID-19 Than With Flu

News Daily News

VTE Risk Higher With COVID-19 Than With Flu

August 18, 2022

CV Symptoms Deserve More Attention, Quantification: AHA Statement

News Daily News

CV Symptoms Deserve More Attention, Quantification: AHA Statement

Yael L. Maxwell

August 18, 2022

Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit

News Daily News

Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit

August 17, 2022

Worse Complications After PVI in Women Highlight Research Gaps

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

August 16, 2022

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

News Daily News

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

Yael L. Maxwell

August 16, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.